Citigroup Inc Merck & Co., Inc. Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
A detailed history of Citigroup Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Citigroup Inc holds 5,107,758 shares of MRK stock, worth $439 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
5,107,758
Previous 6,232,594
18.05%
Holding current value
$439 Million
Previous $559 Million
27.73%
% of portfolio
0.21%
Previous 0.29%
Shares
16 transactions
Others Institutions Holding MRK
# of Institutions
3,842Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$21.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$10.2 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.61 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$5.07 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $218B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...